Table 1.
GHB‐Coma (N = 23) | GHB‐NoComa (N = 22) | No‐GHB (N = 24) | Difference | ||||
---|---|---|---|---|---|---|---|
Mean | ±SD | Mean | ±SD | Mean | ±SD | p | |
Age | 25.52 | 5.62 | 25.86 | 4.44 | 28.04 | 9.41 | 0.402a |
Educational level | 6.57 | 1.67 | 6.91 | 1.11 | 6.63 | 1.28 | 0.672a |
Premorbid IQ | 89.86 | 10.65 | 98.44 | 7.89 | 93.41 | 8.08 | 0.008a , b |
Years since first use | 5.70 | 3.94 | 4.45 | 2.11 | – | – | 0.575c |
Daily dose (mL/day) | 46.77 | 39.19 | 19.69 | 11.36 | – | – | <0.001c |
Days of GHB‐use in preceding 30 days | 11.48 | 12.74 | 2.77 | 2.27 | – | – | 0.085c |
Months of daily use | 25.28 | 45.03 | 0.14 | 0.42 | – | – | 0.008c |
Frame‐wise displacement | 0.10 | 0.05 | 0.08 | 0.02 | 0.09 | 0.02 | 0.170a |
Abbreviations: SD = standard deviation.
Analysis of variance (ANOVA).
Post hoc Tukey HSD: premorbid IQ_GHB‐Coma<GHB‐NoComa p = 0.006.
Mann–Whitney U.